Search results
19 paź 2024 · A literature search based on the PRISMA guidelines for systematic reviews 24 was conducted by SB and SY using the Pubmed® database to find studies that investigated the role of cannabis in the onset, progression, and/or treatment of mood and anxiety symptoms or disorders. Articles published or available online in the English language between ...
28 paź 2019 · The use of pharmaceutical cannabinoids and medicinal cannabis to treat symptoms of mental disorders is increasing. Our study is the most comprehensive review of the evidence to date, including both randomised controlled trials and observational studies of depression, anxiety, ADHD, Tourette syndrome, post-traumatic stress disorder, and psychosis.
17 lis 2023 · In these patients, clinicians should review with patients the risk of cannabis use disorder, assess for existing cannabis use disorder, and offer treatment if it exists. (See "Cannabis use disorder: Clinical features, screening, diagnosis, and treatment", section on 'TREATMENT'.)
3 lut 2021 · Objective: Two primary compounds of the cannabis plant (Cannabis sativa), delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), differentially and dose-dependently affect mood and anxiety.
We analysed the available evidence to ascertain the effectiveness and safety of all types of medicinal cannabinoids in treating symptoms of various mental disorders.
The primary objective was to review the evidence for cannabinoids in treating symptoms of depression, anxiety, post-traumatic stress disorder, attention-deficit hyperactivity disorder, Tic/Tourette syndrome, and psychosis, either as the primary condition or secondary to other conditions.
8 gru 2021 · Approximately 10% of cannabis users report cannabis consumption to treat specific medical disorders or symptoms (2), including stress management and relaxation, treatment of mood and anxiety symptoms, and pain, nausea, and vomiting (3).
